Home » Topics » BioWorld Science

BioWorld Science
RSS

Jubilant Biosys describes PD-1/PD-L1 interaction inhibitors

May 30, 2019

Metacrine reports phase Ib interim data on FXR agonist MET-409 in NASH

May 30, 2019

German researchers present new adenosine A2A receptor ligands

May 30, 2019

Xeomin approved in E.U. for treatment of chronic sialorrhea in adults

May 30, 2019

Sumitomo Dainippon Pharma patents TLR7 antagonists

May 30, 2019

Medshine Discovery divulges mTORC1 and mTORC2 inhibitors

May 30, 2019

Gut-derived live bacterial strains found to modulate neuroinflammation and neurodegeneration in PD

May 30, 2019

TRPV1 as a novel target in gastric cancer therapy

May 30, 2019

Strep genome research expedites vaccine development

May 30, 2019

SNX29 variation plays a role in vasodilator therapy response in PAH

May 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...